ArticleThe Journal of clinical endocrinology and metabolism2026

Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms.

Christoph J Auernhammer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.